HARVARD MANAGEMENT CO INC - Q2 2020 holdings

Add to watchlist

$1.17 Billion is the total value of HARVARD MANAGEMENT CO INC's 19 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 38.9% .

All
New
Buy
Sell
Exit
Unchanged
 Value Shares↓ Weighting
RPRX NewROYALTY PHARMA PLC$713,237,000–14,690,780
+100.0%
60.83%–
UBER BuyUBER TECHNOLOGIES INC$96,727,000
+23.5%
3,112,186
+11.0%
8.25%
-32.7%
GOOGL BuyALPHABET INCcap stk cl a$89,547,000
+174.6%
63,148
+125.0%
7.64%
+49.6%
PANW SellPALO ALTO NETWORKS INC$78,688,000
-59.4%
342,612
-71.0%
6.71%
-77.9%
FB SellFACEBOOK INCcl a$38,553,000
-82.1%
169,783
-86.9%
3.29%
-90.2%
GLD SellSPDR GOLD TRUST$22,155,000
+7.7%
132,372
-4.7%
1.89%
-41.3%
RVMD  REVOLUTION MEDICINES INC$21,164,000
+44.1%
670,3820.0%1.80%
-21.5%
IVV SellISHARES TRcore s&p500 etf$19,747,000
+4.0%
63,763
-13.3%
1.68%
-43.3%
PLRX NewPLIANT THERAPEUTICS INC$18,255,000–562,379
+100.0%
1.56%–
QQQ BuyINVESCO QQQ TRunit ser 1$16,261,000
+32.8%
65,673
+2.1%
1.39%
-27.6%
NCNA SellNUCANA PLCsponsored adr$15,626,000
-7.9%
2,888,311
-0.8%
1.33%
-49.8%
GBIO NewGENERATION BIO CO$10,632,000–506,273
+100.0%
0.91%–
VEA SellVANGUARD TAX-MANAGED FDsftse dev mkt etf$9,028,000
+3.6%
232,738
-11.0%
0.77%
-43.5%
FULC  FULCRUM THERAPEUTICS INC$7,512,000
+53.2%
410,7140.0%0.64%
-16.4%
IJH SellISHARES TRcore s&p mcp etf$3,959,000
+8.0%
22,266
-12.6%
0.34%
-41.1%
IJR SellISHARES TRcore s&p scp etf$3,619,000
+9.3%
52,998
-10.2%
0.31%
-40.3%
VWO SellVANGUARD INTL EQUITY INDEX Fftse emr mkt etf$3,097,000
+2.4%
78,199
-13.2%
0.26%
-44.2%
MGTA  MAGENTA THERAPEUTICS INC$2,498,000
+19.6%
332,6100.0%0.21%
-34.9%
BNTX NewBIONTECH SEsponsored ads$2,127,000–31,869
+100.0%
0.18%–
VIG ExitVANGUARD SPECIALIZED FUNDSdiv app etf$0–-2,858
-100.0%
-0.05%–
NTGN ExitNEON THERAPEUTICS INC$0–-505,871
-100.0%
-0.21%–
PING ExitPING IDENTITY HLDG CORP$0–-405,086
-100.0%
-1.27%–
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2020-08-14
  • View 13F-HR/A filed 2020-09-18
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
ISHARES TR34Q3 202119.4%
VANGUARD TAX-MANAGED INTL FD34Q3 202114.0%
VANGUARD INTL EQUITY INDEX F34Q3 202112.2%
SPDR GOLD TRUST34Q3 20218.7%
ISHARES TR34Q3 20214.9%
META PLATFORMS INC29Q3 202337.6%
VANGUARD SPECIALIZED PORTFOL28Q1 20202.8%
MAGENTA THERAPEUTICS INC21Q2 20231.4%
ALPHABET INC19Q3 202330.4%
ISHARES TR19Q3 20214.4%

View HARVARD MANAGEMENT CO INC's complete holdings history.

Latest significant ownerships (13-D/G)
HARVARD MANAGEMENT CO INC Q2 2020 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
NuCana plcFebruary 12, 20211,678,2393.3%
ADURO BIOTECH, INC.February 08, 2019640,5950.8%
Fortress Transportation & Infrastructure Investors LLCSold outJuly 08, 201600.0%
Alpha Security Group CORPFebruary 13, 2009436,3005.8%
BLOCKBUSTER INCFebruary 13, 20095,567,1007.7%
ChinaGrowth North Acquisition CORPSold outFebruary 13, 200900.0%
ChinaGrowth South Acquisition CORPSold outFebruary 13, 200900.0%
GENEVA ACQUISITION CORPSold outFebruary 13, 200900.0%
Ideation Acquisition Corp.February 13, 2009310,2002.5%
MBF Healthcare Acquisition Corp.February 13, 20091,2200.0%

View HARVARD MANAGEMENT CO INC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-09
13F-HR2023-11-09
13F-HR2023-08-11
13F-HR2023-05-15
13F-HR2023-02-10
13F-HR2022-11-10
13F-HR2022-08-12
13F-HR2022-05-13
13F-HR2022-02-11
13F-HR2021-11-12

View HARVARD MANAGEMENT CO INC's complete filings history.

All filings

View complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported has been amended

Export HARVARD MANAGEMENT CO INC's holdings

CSVXLS